CAP Partners LLC’s Astera Labs ALAB Stock Holding History

CAP Partners LLC’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$223K	Buy	+627	New	+$202K	0.1%	158

Other funds holding ALAB

Salem Investment Counselors Winston Salem, North Carolina $4.01B AUM 48.23% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

Oak Grove Capital North Hampton, New Hampshire $2.21B AUM 127.51% 1-Year Est. Return

Counterpoint Mutual Funds San Diego, California $1.16B AUM 33.78% 1-Year Est. Return

IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return

Linden Thomas Advisory Services Charlotte, North Carolina $1.26B AUM 37.95% 1-Year Est. Return

Sumitomo Mitsui DS Asset Management Tokyo, Japan $14.8B AUM 30.39% 1-Year Est. Return

Decker Retirement Planning Levi, Utah $302M AUM 70.25% 1-Year Est. Return

CAP Partners LLC's ALAB Position: Q3 2026 in Review

CAP Partners LLC opened a new position in Astera Labs (ALAB) in Q3 2026: 627 shares worth $223K. The stake represents 0.1% of the portfolio and ranks #158 among its holdings.

155 funds tracked by Wall St. Rank hold ALAB as of Q3 2026.

CAP Partners LLC held 627 shares of Astera Labs worth $223K as of Q3 2026.
Astera Labs was a new CAP Partners LLC position in Q3 2026.
Astera Labs made up 0.1% of CAP Partners LLC's portfolio in Q3 2026, its #158 holding.
155 funds tracked by Wall St. Rank held Astera Labs as of Q3 2026.

Based on CAP Partners LLC's 13F filing for Q3 2026, filed 19 Oct 2026.